Crossmark

Genetic diversity in the transmission-blocking vaccine candidate Plasmodium vivax gametocyte protein Pvs230 from the China–Myanmar border area and central Myanmar

Crossref DOI link: https://doi.org/10.1186/s13071-022-05523-0

Published Online: 2022-10-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Xin

Hu, Yubing

Zhao, Yan

Wang, Lin

Wu, Zifang

Soe, Myat Thu

Kyaw, Myat Phone

Cui, Liwang

Zhu, Xiaotong

Cao, Yaming
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (U19AI089672)

National Natural Science Foundation of China (81971961)
License Information

Text and Data Mining valid from 2022-10-17

Version of Record valid from 2022-10-17
More Information

Article History

Received: 16 June 2022

Accepted: 27 September 2022

First Online: 17 October 2022

Declarations

:

: The study protocol was approved by China Medical University and by the Health Department of Kachin.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below